Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
CDCA8 upregulation is significantly associated with poor survival and immune infiltration in patients with LUAD. Our study suggests that CDCA8 can be used as a biomarker for LUAD prognosis and a reference for personalized medication.
Authors
- Fangyu Wang (ORCID: https://orcid.org/0000-0002-6388-1461)
- Wenlong Han
- Huiquan Gu (ORCID: https://orcid.org/0000-0003-0377-0732)
- Hanqiang Zhang (ORCID: https://orcid.org/0000-0003-2749-1420)
- Qiang Liu (ORCID: https://orcid.org/0000-0003-4434-2697)
- Weimin Chen (ORCID: https://orcid.org/0000-0002-7768-0759)
- Xinzheng Gao (ORCID: https://orcid.org/0000-0001-5314-986X)
- Longyu Yao
Institutions
- Hainan Medical University (CN)
Publication Details
- Journal
- BMC Medical Genomics
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1186/s12920-024-02019-x
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Natural Science Foundation of China
- China Scholarship Council
- Hainan Medical University